These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5626799)

  • 1. [Basic and clinical studies on the effects of estrogen on pituitary luteinizing hormone excretion].
    Tani T
    Nihon Sanka Fujinka Gakkai Zasshi; 1967 Nov; 19(11):1349-57. PubMed ID: 5626799
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of 0.5 mg lynestrenol on the follicle stimulating hormone, luteinizing hormone, oestrogen and pregnanediol excretion during the menstrual cycle.
    Schmidt-Elmendorff H; Kaiser E; Kopera H
    Arzneimittelforschung; 1969 Aug; 19(8):1277-9. PubMed ID: 5820293
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of ovulation with human postmenopausal gonadotropin. 3. Effect of varying dosage schedules on estrogen and pregnanediol excretion levels.
    Taymor ML; Sturgis SH; Goldstein DP; Lieberman B
    Fertil Steril; 1967; 18(2):181-90. PubMed ID: 6020667
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormone excretion patterns in perimenopausal women.
    Papanicolaou AD; Loraine JA; Dove GA
    J Endocrinol; 1969 Jan; 43(1):xxvi. PubMed ID: 5815249
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urinary excretion of total estrogens, pregnanediol and luteotropic hormone after administration of medroxyprogesterone acetate].
    Wesel S; Bottari P
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):336-7. PubMed ID: 4681539
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of estrogens or estrogen-gestagen combinations, as e.g. ovulation inhibitors on the peripheral venous circulation].
    Hohlweg W
    Z Haut Geschlechtskr; 1969 Sep; 44(18):811-7. PubMed ID: 5382950
    [No Abstract]   [Full Text] [Related]  

  • 7. The mechanism in inhibition of ovulation in oral contraception. 3. The excretion of total pituitary gonadotrophins and luteinizing hormone in fertile women during cyclical treatment with 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone together with 17-alpha-ethynyl-oestradinol-3-methylether.
    Starup J; Lebech PE
    Acta Endocrinol (Copenh); 1967 Oct; 56(2):188-96. PubMed ID: 6072686
    [No Abstract]   [Full Text] [Related]  

  • 8. Pituitary and ovarian function in women on continuous low dose progestogens; effect of chlormadinone acetate and norethisterone.
    Diczfalusy E; Goebelsmann U; Johannisson E; Tillinger KG; Wide L
    Acta Endocrinol (Copenh); 1969 Dec; 62(4):679-93. PubMed ID: 4188441
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of norethisterone enanthate (SH 393) on ovarian function].
    Jürgensen O; Taubert HD; Naujoks H; Fritz I; Kronauer J
    Acta Endocrinol Suppl (Copenh); 1971; 152():65. PubMed ID: 5313575
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone excretion patterns in perimenopausal women.
    Papanicolaou AD; Loraine JA; Dove GA; Loudon NB
    J Obstet Gynaecol Br Commonw; 1969 Apr; 76(4):308-16. PubMed ID: 5778793
    [No Abstract]   [Full Text] [Related]  

  • 11. Central and peripheral action of some progestational steroids.
    Mancuso S; Moneta E
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):441-6. PubMed ID: 5510170
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of various dosages of lynestrenol on the FSH, LH and total gonadotrophin activity during the menstrual cycle.
    Schmidt-Elmendorff H
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):368-73. PubMed ID: 5510165
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mid-cycle fluctuations in ascorbic acid excretion compared with LH and pregnanediol (author's transl)].
    Kemeter P; Spona J; Friedrich F
    Wien Klin Wochenschr; 1974 May; 86(10):277-80. PubMed ID: 4428762
    [No Abstract]   [Full Text] [Related]  

  • 14. Gonadotrophin and steroid interrelationships during the normal menstrual cycle.
    Bell ET; Christie DW
    Steroidologia; 1970; 1(3):152-74. PubMed ID: 4940024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetics of the human pituitary-gonadal system during steroid treatment.
    Nishikawa Y
    Kobe J Med Sci; 1972 Jun; 18(2):109-31. PubMed ID: 4648359
    [No Abstract]   [Full Text] [Related]  

  • 16. The approach of menopause: a New Zealand study.
    Metcalf MG
    N Z Med J; 1988 Mar; 101(841):103-6. PubMed ID: 3132662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of Ro 4-8347 administered from the 5th to 25th of the cycle to women with regular cycle with ovulation].
    Guéguen J
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):428-40. PubMed ID: 5510169
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of some progestins on pituitary gonadotrophin excretion patterns in women.
    Keller PJ
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):379-85. PubMed ID: 5510166
    [No Abstract]   [Full Text] [Related]  

  • 19. [Release of ovulation].
    Tscherne E
    Wien Klin Wochenschr; 1968 Jun; 80(25):486-90. PubMed ID: 5679746
    [No Abstract]   [Full Text] [Related]  

  • 20. [Possibilities for clinical use of synthetic LH-releasing hormone in gynecology].
    Groot-Wassink K; Herrmann U; Rohde W; Ittrich G
    Zentralbl Gynakol; 1973 Jul; 95(30):1010-8. PubMed ID: 4588174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.